Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00491426 · ClinicalTrials.gov registry record
Antimicrobial PK in Infants With Suspected or Confirmed Infection
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 450
- Enrollment target
NCT00491426: Completed study, sponsored by Duke University.
NCT00491426 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 450 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00491426 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
The purpose of this protocol is to provide a mechanism for the ongoing collection of blood and urine samples in newborns that will be used to measure levels of antimicrobial products used in the newborn population where there are limited pharmacokinetic data in either premature or term infants.
Interventions
- DRUG Metronidazole
- DRUG Acyclovir
- DRUG Ampicillin
- DRUG Amphotericin B
- DRUG Piperacillin/Tazobactam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2006-01 |
| Est. Completion | 2010-11 |
What the finished NCT00491426 record still lists
NCT00491426 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Metronidazole is the first listed.
NCT00491426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00491426 about?
NCT00491426 is a clinical study titled "Antimicrobial PK in Infants With Suspected or Confirmed Infection". The purpose of this protocol is to provide a mechanism for the ongoing collection of blood and urine samples in newborns that will be used to measure levels of antimicrobial products used in the newborn population where there are limited pharmacokinetic data in either premature or term infants.
What is the current status of trial NCT00491426?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2006-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00491426?
The interventions under investigation include: Metronidazole (DRUG), Acyclovir (DRUG), Ampicillin (DRUG), Amphotericin B (DRUG), Piperacillin/Tazobactam (DRUG).
Who is sponsoring clinical trial NCT00491426?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia